VIDA yields 20000000.00% · PFE yields 6.20%● Live data
📍 VIDA pulled ahead of the other in Year 1
Combined, VIDA + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of VIDA + PFE for your $10,000?
Vidaroo Corporation, a video technology company, engages in licensing an online video platform and performing professional video production activities. It operates and licenses an online video platform under a software-as-a-service model that consists of a series of Web-based applications, a centralized user console, and an application for the management of the platform. The company's video platform is divided into two editions comprising Publisher, which is divided into a series of modules; and Enterprise edition that allows management of multiple content destinations. It licenses its video platform in on-demand and enterprise programs. The company's video platform provides video management, live streaming, content delivery and syndication, player functionality, social destination, analytics, and advertising capabilities. It is also involved in the creation and support of video imagery in the entertainment business; and support of video production for traditional media and corporate presentations, and in-house production of content. The company was formerly known as Gen2Media Corporation and changed its name to Vidaroo Corporation in April 2010. Vidaroo Corporation is based in Winter Garden, Florida.
Full VIDA Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.